LABORATORY EVALUATION OF IMMUNE HEMOLYTIC ANEMIAS

Course overview

IMMUNE HEMOLYTIC ANEMIAS ARE DISORDERS CHARACTERIZED BY THE IMMUNE SYSTEM TARGETING AND DESTROYING RED BLOOD CELLS (RBCS). THE ETIOLOGY OF THESE ANEMIAS IS MULTIFACETED, INVOLVING AUTOIMMUNE, ALLOIMMUNE, AND DRUG-INDUCED MECHANISMS. FURTHERMORE, THIS LEADS TO CONDITIONS SUCH AS WARM AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA), COLD AGGLUTININ DISEASE, MIXED AIHA, PAROXYSMAL COLD HEMOGLOBINURIA, AND DRUG-INDUCED HEMOLYTIC ANEMIA. DIAGNOSING DIFFERENT TYPES OF IMMUNE HEMOLYTIC ANEMIA REQUIRES A DETAILED INTERPRETATION OF SEVERAL LABORATORY TESTS, INCLUDING COMPLETE BLOOD COUNT (CBC), HAPTOGLOBIN, LACTATE DEHYDROGENASE, RETICULOCYTE COUNT, UNCONJUGATED BILIRUBIN, DIRECT AND INDIRECT ANTIGLOBULIN TESTS, AND PERIPHERAL BLOOD SMEARS. ACCURATE DIAGNOSIS AND MANAGEMENT OF THESE CONDITIONS THROUGH COMPREHENSIVE LABORATORY EVALUATION IMPROVE PATIENT OUTCOMES AND ELEVATE THE STANDARD OF CARE IN HEMATOLOGY AND TRANSFUSION MEDICINE.THIS ACTIVITY PROVIDES A COMPREHENSIVE OVERVIEW OF THE ETIOLOGY, EPIDEMIOLOGY, PATHOPHYSIOLOGY, AND DIAGNOSTIC EVALUATION OF IMMUNE HEMOLYTIC ANEMIAS, HIGHLIGHTING THE COMPLEX INTERPLAY OF IMMUNE MECHANISMS THAT RESULT IN RBC DESTRUCTION AND ANEMIA. THIS ACTIVITY HELPS INTERPROFESSIONAL HEALTHCARE PROVIDERS DIAGNOSE SYMPTOMS ACCURATELY, ADMINISTER TAILORED TREATMENTS, AND DELIVER COMPREHENSIVE PATIENT CARE. IN ADDITION, THIS ACTIVITY ALLOWS CLINICIANS TO ANTICIPATE AND MANAGE POTENTIAL COMPLICATIONS, ELEVATING THE OVERALL STANDARD OF CARE IN HEMATOLOGY AND TRANSFUSION MEDICINE.